SUMOylation in the DNA double-strand break (DSB) response regulates recruitment, activity and 1 2 clearance of repair factors. However, our understanding of a role for deSUMOylation in this process 1 3 is limited. Here we identify different mechanistic roles for deSUMOylation in homologous 1 4 recombination (HR) and non-homologous enjoining (NHEJ) through the investigation of the 1 5 deSUMOylase SENP2. We find regulated deSUMOylation of MDC1 prevents excessive 1 6
G a r v i n e t a l . , 1 0 0 recruitment of the BRCA1-A complex and 53BP1-complex (reviewed in (Panier and Boulton, 2014) ).
0 1
In siSENP2 cells MDC1 co-localization with γ H2AX was observed shortly after IR, however RNF8, 1 0 2 RNF168, Ub conjugates linked through lysine-63 (K63-Ub), 53BP1 and BRCA1 showed incomplete, 1 0 3 or severely reduced, recruitment ( Fig 1E) . Together these data indicate a role for SENP2 in early DSB 1 0 4 signalling.
1 0 5 1 0 6 RNF4-VCP is responsible for defective DNA damage signalling in SENP2 depleted cells.
0 7
To determine the signalling breakpoint in SENP2 deficient cells we examined MDC1, GFP-RNF168 1 0 8 and 53BP1 foci kinetics following IR. Depletion of SENP2 severely reduced the accumulation of 1 0 9 53BP1 and RNF168 foci throughout the time course, however MDC1 foci initially formed in 1 1 0 siSENP2 and SENP2-KO cells and then rapidly became undetectable ( Fig 1F & S1H-I) . The 1 1 1 formation of both MDC1 and 53BP1 foci at later time points, 4 hours after IR, were restored in 1 1 2 SENP2 WT but not SENP2 C548A complemented cells ( Fig 1I-K) suggesting deSUMOylase activity is 1 1 3 important to the persistence of MDC1 at sites of damage and to the accumulation of 53BP1 foci. 1 1 4 1 1 5
To address which factor(s) are responsible for the rapid clearance of MDC1 in SENP2 deficient cells 1 1 6 we first investigated RNF4, whose activity has been implicated in MDC1 turn-over (Galanty et al., 1 1 7 2012; Hendriks et al., 2015; Hendriks and Vertegaal, 2015; Luo et al., 2012; Yin et al., 2012) . Co-1 1 8 depletion of RNF4 with SENP2 resulted in foci kinetics of MDC1, RNF168 and 53BP1 similar to that 1 1 9 of control-treated cells (Fig 1F-H) . The pattern of total SUMO conjugates seen follow IR suggested a 1 2 0 similar relationship between SENP2 and RNF4. Control cells exhibited a global increase in high 1 2 1 molecular weight SUMO conjugates, particularly for SUMO2/3, after treatment ( Fig S2A-B ).
2 2
Whereas in siSENP2 cells, SUMO conjugates were constitutively higher in untreated cells and 1 2 3 showed only a slight increase after IR ( Fig S2A-B) , consistent with the observation of poor DDR 1 2 4 protein recruitment and SUMO IRIF formation. Conjugate patterns after siRNF4+siSENP2 co-1 2 5 depletion resembled those seen in siNTC cells ( Fig S2A-B ) consistent with the near normal DDR foci 1 2 6 kinetics observed on co-depletion. Intriguingly loss of the closely related protease, SENP1, did not 1 2 7 have a similar impact on SUMO conjugates and depleted cells showed an exaggerated induction of 1 2 8 SUMO conjugates following IR ( Fig S2C) . 1 2 9 1 3 0 RNF4 dependent substrate ubiquitination is frequently followed by processing through VCP (Valosin 1 3 1
Containing Protein) hexameric AAA ATPase (Dantuma et al., 2014; Torrecilla et al., 2017) . We 1 3 2 compared the effects of proteasome (MG132) or VCP inhibition (CB-5083) on MDC1 foci loss after 1 3 3 IR. As proteasome inhibition depletes the free Ub pool, in turn causing a failure in Ub signalling in 1 3 4 DSB repair (Butler et al., 2012) , we also transfected the cells with myc-Ub. MG132 treatment resulted 1 3 5 in increased MDC1 foci retention, but in cells expressing additional myc-Ub, foci numbers were 1 3 6
reduced, suggesting Ub, rather than the proteasome is critical to MDC1 foci clearance ( Fig S2D-E) . In 1 3 7 contrast, MDC1 foci persistence in the presence of VCP inhibition was unaffected by Ub expression 1 3 8 ( Fig S2D-E) . Moreover in SENP2 depleted cells, the addition of CB-5083 restored near-normal 1 3 9 MDC1 foci kinetics and the ability to support downstream 53BP1 foci ( Fig 1L-M) . Thus RNF4-VCP 1 4 0 contributes to the rapid MDC1 foci kinetics in SENP2 deficient cells. In a further test for potential nuclear pore involvement we examined cells depleted for nuclear pore 1 4 3 sub-complex components and known SENP2 interacting proteins; NUP153 and NUP107 (Goeres, 1 4 4 G a r v i n e t a l . , 4 2011 #8625). Reduction in NUP107, had no effect on MDC1 kinetics, and NUP153 depletion 1 4 5 modestly increased foci clearance ( Fig S2F) , confirming no substantial involvement of the nuclear 1 4 6 pore in MDC1 kinetics. In contrast when we co-depleted the ligase responsible for MDC1 1 4 7
SUMOylation, PIAS4 (Luo et al., 2012) , we found that siPIAS4 (but not siPIAS1), slowed MDC1 1  7  1 S3F). Next we tested if MDC1 and SENP2 interact and found immunoprecipitated myc-MDC1 co-1 7 2 purified with FLAG-SENP2 in untreated cells, but intriguingly co-precipitation was decreased after 1 7 3 IR ( Fig 2D) . Together these data suggest SENP2 interacts with and restricts MDC1 SUMOylation in 1 7 4 untreated cells.
1 7 5 1 7 6 A conserved coiled-coil region of SENP2 contributes to MDC1 regulation.
7 7
In a search for regions of SENP2 that may contribute to regulation of MDC1-SUMO, we noted a 1 7 8 conserved coiled-coil (CC) domain ( Fig S4A-B) . We generated a 28 aa deletion mutant, removing the 1 7 9 region (∆CC) and found no changes in protein localisation or activity (Fig S4C-F) . However, unlike 1 8 0 SENP2 WT this mutant retained interaction with MDC1 after exposure to IR ( Fig 2D) . In 1 8 1 complementation assays, SENP2 WT permitted increased MDC1 SUMO-2ylation after IR, but cells 1 8 2 expressing SENP2 ∆ CC failed to increase MDC1 SUMOylation (Fig 2E) . Moreover cells complemented 1 8 3 with SENP2 ∆ CC failed to clear MDC1 foci and were radiosensitive ( Fig 2F-H) . These data suggest that 1 8 4 cancers often receive post-operative radiotherapy so further investigation into the potential of 3 5 1 targeting SENP2 in the context of chromosome 3q amplification is warranted.
3 5 2 3 5 3
In summary the need for the SUMO protease, SENP2, in aspects of mammalian DSB repair presented 3 5 4 here reveal unexpected requirements for SUMO deconjugation, and its regulation, in the DNA 3 5 5 damage response and place the need for the activity largely in undamaged cells before the stress of 3 5 6
DSBs occurs. We find deSUMOylation by SENP2, prevents engagement of RNF4-VCP with MDC1, 3 5 7 restricting an 'over-before-it-has begun' repair response and promotes SUMO supply, critical to the 3 5 8 completion of HR, while increased SENP2 expression dramatically dysregulates DSB repair 3 5 9 3 9 8 experiment contained 3 technical repeats and normalized to siRNA controls or to WT-complemented Cells were plated on 13 mm circular glass coverslips at a density of 5 x 10 4 cells/ml, treated as 4 0 5 required. For RPA, and RAD51 staining cells were pre-extracted in CSK buffer (100 mM sodium 4 0 6 chloride, 300 mM sucrose, 3 magnesium chloride , 10 mM PIPES pH 6.8) for 1 minute at room 4 0 7 temperature, For all other staining's cells were first fixed in 4% PFA and permeabilised with 0.5%
0 8
Triton X100 in PBS. After blocking in 10% FCS, cells were incubated with primary antibody for 1 hr 4 0 9
(unless otherwise stated) and with secondary AlexaFluor antibodies for 1 hr. The DNA was stained 4 1 0 using Hoechst at 1:20,000. In some images the DNA stain has been drawn around (but not shown) to 4 1 1 illustrate the location of the nucleus. 4 1 2 RAD51 foci: Cells were labelled with 10 µM EdU 1 hr prior to IR using a Gamma-cell 1000 Elite 4 1 3 irradiator (caesium-137 source). At 4 hr post-IR cells were washed briefly in CSK buffer (100 mM 4 1 4 sodium chloride, 300 mM sucrose, 3 mM magnesium chloride, 10 mM PIPES pH 6.8) before fixation 4 1 5 with 4 % Paraformaldehyde for 10 min. For IF staining cells were permeabilised with 0.2%
1 6
TritonX100 in PBS for 10 min before blocking in 10 % FBS in PBS. EdU was visualised by Click-4 1 7 iT® chemistry according to the manufacturer's protocols (Life Technologies) with Alexa-647-azide.
1 8
Cells were incubated with primary antibody overnight, washed three times in PBS and incubated with 4 1 9 secondary AlexaFluor antibodies for 1 hr.
2 0
With the exception of Figure 1G -H all immunofluorescent staining was imaged using the Leica HeLa FlpIn or HeLa FlpIn SENP2 WT cells were plated on 60mm plates in the presence of doxycycline for 5 0 0 48 hr prior to irradiation at 2 Gy. Eighteen hr later cells were incubated with Colcemid (0.05 μg/ml) 6 5 0 1 hr. Cells were then trypsinized and centrifuged at 1200 rpm for 5 minutes. Supernatant was discarded 5 0 2 and cells re-suspended. 5 ml of ice-cold 0.56% KCl solution was then added and incubated at room 5 0 3 temperature for 15 min before centrifuging at 1200 rpm for 5 min. Supernatant was discarded and cell 5 0 4 pellet broken before fixation. Cells were then fixed in 5 ml of ice-cold methanol: glacial acetic acid 5 0 5
(3:1). Fixation agents were removed and 10 μl of cells suspension was dropped onto alcohol cleaned 5 0 6 slide. Slides were allowed to dry at least 24 hr and then stained with Giemsa solution ( Sigma) diluted 5 0 7 1:20 for 20 min. Slide mounting was performed with Eukitt ( Sigma).
0 8
Overexpression and purification of MDC1 WT and MDC1 K1840R (aa 1818-2094) C-terminal domains.
0 9
The expression of His-SUMO MDC1 WT and His-SUMO-MDC1 K1840R in BL21(DE3*)/pCA528-5 1 0 MDC1 was induced by the addition of 1 mM Isopropyl-β-d-thiogalactopyranoside (IPTG), and the 5 1 1 proteins were produced in LB medium containing 100 μ g/ml of kanamycin overnight at 18°C. For 5 1 2 purification of the His-SUMO MDC1 WT and His-SUMO MDC1 K1840R products, the cells were 5 1 3
harvested and re-suspended in 20 mM HEPES potassium salt, pH 7.4, 50 mM Imidazole, 500 mM 5 1 4
NaCl, 1.0 mM TCEP [tris(2-carboxyethyl)phosphine], complete EDTA-free protease inhibitor 5 1 5 cocktail tablet (Roche). Cells were lysed using an Emulsiflex-C3 homogenizer (Avestin) and broken 5 1 6 by three passages through the chilled cell. The lysate was centrifuged at 75,000 xg using a JA 25 rotor 5 1 7 (Beckman Coulter) and filtered through a 0.45-μm filter. The clarified lysate was applied onto a 5-ml 5 1 8
HisTrap HP column (GE Healthcare). The column was washed extensively using the same buffer, and 5 1 9 the protein was eluted using buffer containing 500 mM imidazole.
. ,
2
Fractions containing a band of the correct size were concentrated using a Vivaspin 20-ml concentrator 5 2 1 (10,000 molecular weight cut-off [MWCO]) (GE Healthcare) and gel purified using an Akta Pure 25 5 2 2 (GE Healthcare LS) with a prepacked Hi-Load 10/300 Superdex 200 PG column.
2 3
For removal of the His-SUMO tag, 1ul of ULP-1 (20mg/ml) was added to 5ml of His-SUMO 5 2 4 MDC1 WT and His-SUMO-MDC1 K1840R and left overnight at 4°C. The samples were concentrated to 5 2 5 500μl using a Vivaspin 4-ml concentrator (10,000 molecular weight cut-off [MWCO]) (GE 5 2 6
Healthcare) and gel purified on a Hi-Load 10/300 Superdex 75 PG column in order to separate the 5 2 7
untagged proteins from the ULP-1 protease and the cleaved His-SUMO tag.
2 8
In vitro SUMOylation assay 5 2 9
In vitro SUMOylation assay reactions were typically performed in a total volume of 20 μl with 200 ng 1h and stopped by addition of 2x Laemmli loading buffer.
3 5
In vitro deSUMOylation assay. A. IR colony survival in HeLa treated with siNTC or siSENP2 for 72 hr. Cells were treated concurrently with dox (1μg/mL) to induce siRNA resistant forms of SENP2, n=4. B-C. HR (U2OS DR3-GFP) or NHEJ (U2OS-EJ5-GFP) assays using siSENP2 or siNTC treated cells transfected with RFP, I-SceI and SENP2 WT or SENP2 C548A . GFP+ cells were normalised to RFPtransfection efficiency. %-repair is given compared to siNTC. Western blot shows SENP2 knockdown efficiency and restoration with siRNA resistant cDNA, n=3. D-E. SUMO / γ H2AX co-localising foci in HeLa siNTC or siSENP2 cells fixed 1 hr post 5 Gy IR. E) as for D with indicated DDR factors, n=3. F-H. Time course of MDC1 (n=200), GFP-RNF168 (n=50) or 53BP1 (n=150) foci in HeLa treated with indicated siRNA. Representative images for 53BP1 foci at 4 hr post IR are shown. I-K. MDC1 and 53BP1 foci/cell respectively 4 hr post 4 Gy IR in siNTC or siSENP2 HeLa. K) representative images related to I), n=100 cells. L-M. HeLa (siNTC / siSENP2) irradiated with 4 Gy and 0.5 hr later treated with DMSO / 0.1μM VCPi, CB-5083. Cells were fixed at the indicated times and scored for MDC1 foci. M) As for L but 53BP1 foci in cells fixed at 2 hr, n=100 cells. Data shows kinetics of foci/cell for the indicated times post treatment with 4 Gy IR. B) As for A but 53BP1 foci at 2 hr. n=100. C. HEK293 6x-His-myc SUMO2 treated with indicated siRNA (48 hr), irradiated (10 Gy), lysed 1 hr later and subjected to Ni 2+ agarose purification, followed by immunoblotting with MDC1 antibodies to determine the relative enrichment in SUMO2 conjugates. PD = Pulldowns. D. HEK293 myc-MDC1 WT transiently transfected with FLAG-SENP2 WT or SENP2 ∆ CC and treated with dox (72 hr). Cells were irradiated (4 Gy) and lysed 1 hr later followed by immunoprecipitation with myc-agarose. E. As for C, but cells were transfected 24 hr post siRNA knockdown with SENP2 WT or SENP2 ∆ CC .
F-G. HeLa treated with siSENP2. 24 hr later cells were transfected with FLAG-SENP2 for 48 hr, irradiated (4 Gy) and fixed at indicated times. G) MDC1 foci/cell were measured in cells co-staining with FLAG-SENP2, n=50. H. Colony survival in IR (2 Gy) HeLa treated with siNTC, siSENP2 or siSENP2 plus dox to induce expression of SENP2 mutants, n=3. a  m  o  l  i  a  t  t  e  ,  F  .  ,  C  a  r  o  n  ,  D  .  ,  D  u  r  e  t  t  e  ,  C  .  ,  M  a  h  r  o  u  c  h  e  ,  L  .  ,  M  a  r  o  u  i  ,  M  .  A  .  ,  C  a  r  o  n  -L  i  z  o  t  t  e  ,  O  .  ,  B  o  n  n  e  i  l  ,  E  .  ,  7  3  5  C  h  e  l  b  i  -A  l  i  x  ,  M  .  K  .  ,  a  n  d  T  h  i  b  a  u  l  t  ,  P  .  (  2  0  1  4  )  .  L  a  r  g  e  -s  c  a  l  e  a  n  a  l  y  s  i  s  o  f  l  y  s  i  n  e  S  U  M  O  y  l  a  t  i  o  n  b  y  S  U  M  O  7  3  6  r  e  m  n  a  n  t  i  m  m  u  n  o  a  f  f  i  n  i  t  y  p  r  o  f  i  l  i  n  g  .  N  a  t  C  o  m  m  u  n   5   ,  5  4  0  9  .  7  3  7  L  e  e  ,  M  .  H  .  ,  M  a  b  b  ,  A  .  M  .  ,  G  i  l  l  ,  G  .  B  .  ,  Y  e  h  ,  E  .  T  .  ,  a  n  d  M  i  y  a  m  o  t  o  ,  S  .  (  2  0  1  1  )  .  N  F  -k  a  p  p  a  B  i  n  d  u  c  t  i  o  n  o  f  t  h  e  7  3  8  S  U  M  O  p  r  o  t  e  a  s  e  S  E  N  P  2  :  A  n  e  g  a  t  i  v  e  f  e  e  d  b  a  c  k  l  o  o  p  t  o  a  t  t  e  n  u  a  t  e  c  e  l  l  s  u  r  v  i  v  a  l  r  e  s  p  o  n  s  e  t  o  g  e  n  o  t  o  x  i  c  7  3 
